Axovant Sciences Company

Axovant Sciences is a leading clinical-stage neurology company focused on the treatment of dementia and related neurological disorders. Axovant is developing a pipeline of product candidates to comprehensively address the cognitive, functional, and behavioral aspects of dementia. Vision of the company is to become the leading company focused on the treatment of dementia by broadly addressing multiple forms of this condition through developing innovative new medicines for patients.

Headquarters: Basel, Basel-Stadt, Switzerland
Funding Status: IPO
Employee Number: 51-100
Investment Stage: N/A
Number Of Exists: N/A
Technology: Cell therapy
Investor Type: N/A
Founded Date: 2014
Industry: Regenerative Medicine